Teva to hire 200 at new Philly facility

Teva Pharmaceuticals USA, the American arm of the Israeli generics maker, will create 200 jobs at a distribution facility it plans to open in Northeast Philadelphia. Report

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.